Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation
BLOOD CANCER JOURNAL（2022）
关键词
Chronic myeloid leukaemia,Genetics research,Innate immunity,Risk factors,Biomedicine,general,Cancer Research,Oncology,Hematology
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要